Vancomycin Supplier-Buyer Network — Trade Flow Analysis

Name: Vancomycin Supplier-Buyer Trade Network Dataset — 318+ Indian Exporters, 19+ Importers, 140+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Vancomycin supplier network, Vancomycin buyers, pharmaceutical export India, Vancomycin trade data

TransData Nexus

Vancomycin

India Pharmaceutical Trade Intelligence

$92.2M318 Suppliers140 CountriesHS 30042096

ExportsIndia → UNITED STATES54.8%India → GERMANY8.8%

ImportsCHINA → India$301.9K UNITED STATES → India$74.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN INSTITUTIONAL

Who Supplies Vancomycin? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Vancomycin exporter from India, with a market share of 19.1% and a total export value of $17.6M across 319 shipments. Their average shipment value of $55.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN INSTITUTIONAL INC is the dominant customer, accounting for 51.8% of this supplier's tracked business. Top customers include:

• MYLAN INSTITUTIONAL INC — $9.1M across 165 shipments (51.8% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC — $6.6M across 120 shipments (37.6% of this supplier's total exports)

• MYLAN AUSTRALIA — $1.2M across 23 shipments (7.1% of this supplier's total exports)

• M S MYLAN INSTITUTIO — $338.8K across 6 shipments (1.9% of this supplier's total exports)

• MYLAN PHARMACEUTICAL — $293.7K across 5 shipments (1.7% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $55.1K is 83% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Vancomycin exporter from India, with a market share of 7.6% and a total export value of $7.0M across 40 shipments. Their average shipment value of $176.2K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EUGIA US LLC, — $3.4M across 19 shipments (48.7% of this supplier's total exports)

• EUGIA US LLC, — $2.9M across 17 shipments (41.4% of this supplier's total exports)

• NORTHSTAR DISTRIBUTI — $477.5K across 3 shipments (6.8% of this supplier's total exports)

• NORTHSTAR HEALTHCARE — $140.2K across 1 shipments (2.0% of this supplier's total exports)

• NORTHSTAR HEALTHCARE — $80.2K across 0 shipments (1.1% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $176.2K is 487% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

3STRIDES PHARMA SCIENCE LIMITED

STRIDES PHARMA SCIENCE LIMITED is the third-largest Vancomycin exporter from India, with a market share of 6.2% and a total export value of $5.7M across 220 shipments. Their average shipment value of $25.9K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.

STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR.FRIEDRICH EBERTH ARZNEIMITTEL — $2.7M across 106 shipments (48.0% of this supplier's total exports)

• STRIDES NORDIC APS — $914.2K across 35 shipments (16.0% of this supplier's total exports)

• AVET PHARMACCEUTICALS INC., — $896.3K across 35 shipments (15.7% of this supplier's total exports)

• DR.FRIEDRICH EBERTH ARZNEIMITTEL — $662.6K across 26 shipments (11.6% of this supplier's total exports)

• DR FRIEDRICH EBERTH — $490.3K across 19 shipments (8.6% of this supplier's total exports)

Key Insight: STRIDES PHARMA SCIENCE LIMITED operates with high shipment frequency (220 shipments) at a per-shipment value of $25.9K, indicating a broad distribution network with many smaller, regular orders.

4GLAND PHARMA LTD

GLAND PHARMA LTD is the fourth-largest Vancomycin exporter from India, with a market share of 5.3% and a total export value of $4.9M across 59 shipments. Their average shipment value of $83.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

GLAND PHARMA LTD serves 5 named buyers in our database. EVERSANA is the dominant customer, accounting for 73.5% of this supplier's tracked business. Top customers include:

• EVERSANA — $3.6M across 43 shipments (73.5% of this supplier's total exports)

• EVERSANA — $422.7K across 5 shipments (8.6% of this supplier's total exports)

• INTEGRATED COMMERCIALIZATION — $356.3K across 4 shipments (7.3% of this supplier's total exports)

• EVERSANA LIFE SCIENC — $290.8K across 3 shipments (5.9% of this supplier's total exports)

• GLENMARK PHARMACEUTI — $228.6K across 3 shipments (4.7% of this supplier's total exports)

Key Insight: GLAND PHARMA LTD's per-shipment value of $83.1K is 177% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

5GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the fifth-largest Vancomycin exporter from India, with a market share of 5.2% and a total export value of $4.8M across 108 shipments. Their average shipment value of $44.3K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA EVERSANA — $2.4M across 54 shipments (49.6% of this supplier's total exports)

• EVERSANA — $1.1M across 24 shipments (22.3% of this supplier's total exports)

• INTEGRATED COMMERCIALIZATION — $861.1K across 19 shipments (18.0% of this supplier's total exports)

• EVERSANA — $282.8K across 6 shipments (5.9% of this supplier's total exports)

• ALMAJECT — $201.2K across 5 shipments (4.2% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $44.3K is 48% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

6ASPIRO PHARMA LIMITED

ASPIRO PHARMA LIMITED is the fifth-largest Vancomycin exporter from India, with a market share of 3.6% and a total export value of $3.3M across 149 shipments. Their average shipment value of $22.4K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.

ASPIRO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $1.4M across 63 shipments (42.5% of this supplier's total exports)

• SAUDI AMAROX FOR INDUSTRY — $1.2M across 51 shipments (34.5% of this supplier's total exports)

• TO THE ORDER OF — $380.3K across 17 shipments (11.4% of this supplier's total exports)

• SEVEN PHARMA CHILE S — $195.7K across 9 shipments (5.9% of this supplier's total exports)

• SAUDI AMAROX FOR INDUSTRY — $193.5K across 9 shipments (5.8% of this supplier's total exports)

Key Insight: ASPIRO PHARMA LIMITED operates with high shipment frequency (149 shipments) at a per-shipment value of $22.4K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Vancomycin imports from India, with a total trade value of $50.6M across 381 shipments — representing a 54.8% share of all Vancomycin exports. The average shipment value of $132.7K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.

Named Vancomycin importers in United States: MYLAN INSTITUTIONAL INC 2898 is the largest buyer, accounting for 20.7% ($10.5M) of this market's total imports.

• MYLAN INSTITUTIONAL INC 2898 — $10.5M (20.7% of United States's total)

• MYLAN INSTITUTIONAL INC — $7.1M (14.0% of United States's total)

• EVERSANA — $6.6M (13.1% of United States's total)

Key Insight: United States's per-shipment average of $132.7K (342% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Vancomycin imports from India.

Primary Market

Secondary Market

2Germany

Germany ranks as the second-largest destination for Vancomycin imports from India, with a total trade value of $8.1M across 103 shipments — representing a 8.8% share of all Vancomycin exports. The average shipment value of $78.9K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Vancomycin importers in Germany: DR.FRIEDRICH EBERTH ARZNEIMITTEL is the largest buyer, accounting for 40.3% ($3.3M) of this market's total imports.

• DR.FRIEDRICH EBERTH ARZNEIMITTEL — $3.3M (40.3% of Germany's total)

• HANSE SERVICE INTERNATIONALE — $2.8M (34.6% of Germany's total)

Key Insight: Germany's per-shipment average of $78.9K (163% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Vancomycin imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Vancomycin imports from India, with a total trade value of $4.4M across 70 shipments — representing a 4.8% share of all Vancomycin exports. The average shipment value of $63.0K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Vancomycin importers in Australia: MYLAN AUSTRALIA is the largest buyer, accounting for 63.3% ($2.8M) of this market's total imports.

• MYLAN AUSTRALIA — $2.8M (63.3% of Australia's total)

• ASPEN PHARMACARE PTY LTD, — $916.1K (20.8% of Australia's total)

Key Insight: Australia's per-shipment average of $63.0K (110% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Vancomycin imports from India.

Primary Market

Secondary Market

4Saudi Arabia

Saudi Arabia ranks as the fourth-largest destination for Vancomycin imports from India, with a total trade value of $2.7M across 11 shipments — representing a 2.9% share of all Vancomycin exports. The average shipment value of $246.6K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Vancomycin importers in Saudi Arabia: SAUDI AMAROX FOR INDUSTRY is the largest buyer, accounting for 42.5% ($1.2M) of this market's total imports.

• SAUDI AMAROX FOR INDUSTRY — $1.2M (42.5% of Saudi Arabia's total)

Key Insight: Saudi Arabia's per-shipment average of $246.6K (721% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Vancomycin imports from India.

Primary Market

Secondary Market

5Ethiopia

Ethiopia ranks as the fifth-largest destination for Vancomycin imports from India, with a total trade value of $2.6M across 0 shipments — representing a 2.9% share of all Vancomycin exports. The average shipment value of $2.6M is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Ethiopia's per-shipment average of $2.6M (8718% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ethiopia is a key market for Vancomycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Vancomycin.
2.Flow Mapping: 318 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,071 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 140 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,071 Verified Shipments

318 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Vancomycin

Vancomycin

Who Supplies Vancomycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Vancomycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Vancomycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3STRIDES PHARMA SCIENCE LIMITED

4GLAND PHARMA LTD

5GLAND PHARMA LIMITED

6ASPIRO PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Vancomycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Vancomycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Germany

3Australia

4Saudi Arabia

5Ethiopia

People Also Ask — Vancomycin Supplier & Trade Network

Vancomycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology